{"text": ["AbbVie", "(ABBV)", "Shares", "Cross", "5%", "Yield", "Mark"], "created_at": "2018-11-21 22:07:12"}
{"text": ["AbbVie", "(ABBV)", "Shares", "Cross", "5%", "Yield", "Mark"], "created_at": "2018-11-21 22:07:12"}
{"text": ["AbbVie", "Receives", "US", "FDA", "Accelerated", "Approval", "for", "VENCLEXTA\u00ae", "(venetoclax)", "for", "Treatment", "of", "Newly-Diagnosed", "Acute", "Myeloid", "Leukemia", "Patients", "Ineligible", "for", "Intensive", "Chemotherapy"], "created_at": "2018-11-21 19:14:00"}
{"text": ["The", "Klein", "Law", "Firm", "Reminds", "Investors", "of", "Class", "Actions", "on", "Behalf", "of", "Shareholders", "of", "ABBV,", "MGTI,", "ACHC,", "JT", "and", "HTHT"], "created_at": "2018-11-21 16:00:00"}
{"text": ["AbbVie", "(ABBV)", "Stock", "Moves", "-1.55%:", "What", "You", "Should", "Know"], "created_at": "2018-11-21 01:09:40"}
{"text": ["AbbVie", "(ABBV)", "Stock", "Moves", "-1.55%:", "What", "You", "Should", "Know"], "created_at": "2018-11-21 01:09:40"}
